Triacetoxyperiodinane → (Rac)-3-[1-(6-fluoro-1-methyl-1h-indazol-5-yl)-ethyl]-6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazine

HRID 69281Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 69281
Cl[C:2]1[CH:3]=[CH:4][C:5]2[N:6]([C:8]([CH:11]([C:13]3[CH:14]=[C:15]4[C:19](=[CH:20][C:21]=3[F:22])[N:18]([CH3:23])[N:17]=[CH:16]4)O)=[CH:9][N:10]=2)[N:7]=1.ClC1C=CC2N(C(C(C3C=[C:38]4[C:42](=CC=3F)[N:41]([CH3:46])[N:40]=[CH:39]4)=O)=CN=2)N=1.[CH3:47]C(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O>C(Cl)Cl>[F:22][C:21]1[CH:20]=[C:19]2[C:15]([CH:16]=[N:17][N:18]2[CH3:23])=[CH:14][C:13]=1[CH:11]([C:8]1[N:6]2[N:7]=[C:2]([C:38]3[CH:39]=[N:40][N:41]([CH3:46])[CH:42]=3)[CH:3]=[CH:4][C:5]2=[N:10][CH:9]=1)[CH3:47]

Komponenten

4

Versuchsvorschrift

(6-Chloro-imidazo[1,2-b]pyridazin-3-yl)-(6-fluoro-1-methyl-1H-indazol-5-yl)-methanone (rac)-(6-Chloro-imidazo[1,2-b]pyridazin-3-yl)-(6-fluoro-1-methyl-1H-indazol-5-yl)-methanol (Stage 278.4, 4.2 g, 12.66 mmol) was suspended in DCM (250 mL). Dess-Martin periodinane (10.64 g, 38.0 mmol) was added and the mixture was stirred at rt for 1.5 h. The mixture was evaporated to dryness and the residue was taken in 1 M NaOH and sonicated. After 15 min of stirring, it was filtered. The precipitate was dried under vacuum overnight to afford the title compound (tR 1.13 min (conditions 2), MH+=330)

Aufarbeitung

  1. customThe mixture was evaporated to dryness
  2. customsonicated
  3. stirringAfter 15 min of stirring
  4. filtrationit was filtered
  5. customThe precipitate was dried under vacuum overnight

Quellen und Nachweise

ORD-Eintrag
ord-a13de345a6974dab8fedd4a3fc22da45
Quelldatensatz
uspto-grants-2014_09
Patentnummer
US08822468B2

Notizen zur Reaktion

Wird geladen…